News The latest from Sage
PATIENTS & CARE PARTNERS Putting patients and their families first
We are rethinking care and how it is delivered to help patients and families impacted by brain health disorders.
HEALTHCARE PROVIDERS It’s an exciting time in neuroscience
At Sage, our goal is to originate meaningfully differentiated drug candidates. We aim to discover new pathways to brain health by making medicines that matter so patients can get better, sooner.
CLINICAL TRIALS A distinct approach to neuroscience drug developmentSage is committed to developing new medicines to treat life-altering brain health disorders.
PIPELINE Advancing a leading brain health portfolioWe seek to make a positive impact on the unmet treatment needs of patients by advancing product candidates from a robust development pipeline of potential brain health disorder treatments.
(brexanolone) CIV injection